Bioventix (LON:BVXP) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

Bioventix PLC (LON:BVXP) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 2,210.20 and traded as low as GBX 1,850. Bioventix shares last traded at GBX 1,855, with a volume of 21,306 shares traded.

Bioventix Trading Down 0.2%

The company has a market capitalization of £99.07 million, a P/E ratio of 13.23 and a beta of 0.35. The business has a 50 day moving average price of GBX 1,831.13 and a 200 day moving average price of GBX 2,210.20.

Bioventix (LON:BVXP) last issued its quarterly earnings data on Monday, October 27th. The biotechnology company reported GBX 145.27 earnings per share (EPS) for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. On average, analysts forecast that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Peter John Harrison purchased 875 shares of the firm’s stock in a transaction dated Tuesday, November 4th. The stock was bought at an average price of GBX 2,220 per share, with a total value of £19,425. Also, insider Bruce Hiscock acquired 150 shares of the stock in a transaction that occurred on Tuesday, November 25th. The stock was purchased at an average price of GBX 2,071 per share, with a total value of £3,106.50. Company insiders own 6.16% of the company’s stock.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.